Functional studies have shown that knockdown of SphK2 expression or use of selective inhibitors can significantly inhibit cancer cell proliferation, migration, and invasion, with mechanisms involving induction of apoptosis and enhanced chemotherapy sensitivity (47). The gene discussed is SPHK2; the disease is cancer.